West Pharmaceutical Services Inc. Stock
West Pharmaceutical Services Inc. shows a slight decrease today, losing -€2.200 (-0.960%) compared to yesterday.
West Pharmaceutical Services Inc. is currently one of the favorites of our community with 12 Buy predictions and no Sell predictions.
With a target price of 297 € there is a positive potential of 30.95% for West Pharmaceutical Services Inc. compared to the current price of 226.8 €.
Pros and Cons of West Pharmaceutical Services Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of West Pharmaceutical Services Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| West Pharmaceutical Services Inc. | -0.960% | 0.483% | 9.674% | 21.647% | -2.262% | -30.816% | -12.662% |
| Haemonetics Corp. | 1.940% | 6.275% | 0.962% | - | -23.358% | - | - |
| Bio-Rad Labs Inc. A | -1.120% | 2.745% | 8.763% | 14.670% | -4.226% | -43.349% | -52.952% |
| CONMED Corp. | -0.620% | 5.063% | 2.469% | -20.952% | -5.143% | -66.294% | -69.541% |
Comments
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for WST provided by MarketBeat